Center For Comprehensive Care and Diagnosis of Inherited Blood is a 501(c)(3) organization based in Orange, California, registered in 2010, with $23,337,253 in FY2023 revenue. CharityIndex grades it A, and it directs about 85% of spending to programs.
Revenue (FY2023)
$23.3M
▲ 16.3% vs prior year
Health median: $840K
Expenses (FY2023)
$16.9M
Net assets
$50.3M
Employees
57
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Center For Comprehensive Care and Diagnosis of Inherited Blood: 85% to programs · $0 to raise $100 earns a A on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Center For Comprehensive Care and Diagnosis of Inherited Blood: 36 mo reserves · +27% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Center For Comprehensive Care and Diagnosis of Inherited Blood: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Center For Comprehensive Care and Diagnosis of Inherited Blood: 4 of 5 disclosure signals earns a A on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
To improve health and longevity and lower costs of care; by providing education, support, and services to deliver comprehensive care for patients and their families with rare, chronic inherited blood disorders.
Revenue declined from $25.8M (FY2013) to $23.3M (FY2023) across 11 reported years.
Financial snapshot
Operating margin
27.4%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$71.3M
Total liabilities
$21.0M
Net assets
$50.3M
Salaries & benefits
$7.6M
45% of expenses
Board members
6
6 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $23,337,253▲16.3% | $16,931,546▼10.1% | $50,331,932▲19.6% | $71,349,404▲16.4% | 990 |
| 2022 | $20,062,547▲65.2% | $18,826,320▲21.7% | $42,075,695▲3.0% | $61,282,179▲31.9% | 990 |
| 2021 | $12,142,094▲5.4% | $15,472,104▲5.9% | $40,839,468▼10.6% | $46,446,654▼12.9% | 990 |
| 2020 | $11,525,331▼83.2% | $14,614,485▼79.5% | $45,704,280▼6.3% | $53,330,145▼5.3% | 990 |
| 2019 | $68,646,232▼4.8% | $71,221,235▲37.1% | $48,793,434▼5.0% | $56,342,926▼0.6% | 990 |
| 2018 | $72,084,713▲17.6% | $51,953,005▲27.1% | $51,368,437▲64.4% | $56,670,406▲59.3% | 990 |
| 2017 | $61,281,622▲42.8% | $40,887,659▲3.6% | $31,236,729▲188% | $35,584,652▲154% | 990 |
| 2016 | $42,914,817▲22.5% | $39,478,977▲20.5% | $10,842,766▲46.4% | $14,003,520▲34.3% | 990 |
| 2015 | $35,036,973▲18.6% | $32,773,735▲18.6% | $7,406,926▲44.0% | $10,426,826▲35.6% | 990 |
| 2014 | $29,552,169▲14.5% | $27,641,679▲13.5% | $5,143,688▲59.1% | $7,692,170▲21.8% | 990 |
| 2013 | $25,801,564 | $24,355,180▲12.3% | $3,233,198▲80.9% | $6,314,022▲51.4% | 990 |
| 2012 | — | $21,689,856▲30.8% | $1,786,815▼10.6% | $4,171,319▼17.8% | 990 |
| 2011 | — | $16,586,224▲72.5% | $1,999,104▼21.6% | $5,072,863▼9.8% | 990 |
| 2010 | — | $9,615,227 | $2,550,453 | $5,621,855 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Barry Staton — $400,120 (2.36% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Barry Staton | Chief Executive Officer & Treasurer | 40 | $400,120 |
| Esteban Gomez | Physician | 32 | $293,324 |
| Michael Warden | Chief Financial Officer | 40 | $255,018 |
| Vanessa Salinas Luna | Physician | 40 | $218,347 |
| Robin Tappey | Human Resources Director | 40 | $210,904 |
| Nina Hwang | Physician | 32 | $204,261 |
| Matthew Cianciulli | Director of Clinic | 40 | $199,987 |
| Samantha Chan | Pharmacy Manager | 40 | $199,399 |
| Shalini Vora | Grants Director | 40 | $155,545 |
| Jeralyn Tucker | Clinic Manager | 40 | $151,355 |
| Amit Soni Md | Vice President | 5 | — |
| Bertil Glader Md Phd | Director | 1 | — |
| Diane J Nugent Md | President/chairperson | 5 | — |
| Katie Birschbach | Secretary | 1 | — |
| Mary Brown | Director | 0.5 | — |
| Randall Curtis | Director | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Children's Hospital Orange County | Contractual Services | $1,595,693 |
| Sickle Cell Foundation of Southern Calif | Contractual Services | $515,362 |
| Reseachdx Inc | Contractual Services | $231,251 |
| Pediatric Subspecialties | Contractual Services | $206,108 |
| Pacific Environmental Technologies Inc | Contractual Services | $164,029 |
1 grant to Center For Comprehensive Care and Diagnosis of Inherited Blood totaling $5,831, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| University of Pittsburgh | Research- subcontract | 2020 | $5,831 |
23 grants totaling $3.7M in FY2023 — showing the 15 largest. All grants made by Center For Comprehensive Care and Diagnosis of Inherited Blood →
| Recipient | Purpose | Amount |
|---|---|---|
| University of California San Francisco | Subcontract hrsa & cdph grants sickle cell treatment demonstration program | $829,478 |
| Sickle Cell Disease Foundation of California | Subcontract hrsa & cdph grants sickle cell treatment demonstration program | $515,362 |
| The Regents of the University of California (davis) | Subcontract hrsa & cdph grants sickle cell treatment demonstration program | $422,685 |
| Regents of the University of California At San Diego | Subcontract hrsa & cdph grants sickle cell treatment demonstration program | $229,139 |
| Childrens Hospital & Research Center Foundation | Subcontract hrsa grant sickle cell treatment demonstration program | $192,143 |
| Arrowhead Regional Medical Center | Subcontract cdph grant sickle cell treatment demonstration program | $146,456 |
| The University of Arizona | Subcontract hrsa grant sickle cell treatment demonstration program | $134,163 |
| Regents Univ of California | Subcontract cdph grant sickle cell treatment demonstration program | $134,163 |
| Valley Childrens Hospital | Subcontract hrsa grant hemophilia regional comprehensive care program | $129,423 |
| Lundquist Institute For Biomedical Innovation At Harbor-ucla Medical | Subcontract cdph grant sickle cell treatment demonstration program | $118,578 |
| Loma Linda University Health Care | Subcontract cdph grant sickle cell treatment demonstration program | $110,193 |
| Hemostasis and Thrombosis Center of Nevada | Subcontract hrsa grant hemophilia regional comprehensive care program | $106,944 |
| Kern Medical Center Foundation | Subcontract cdph grant sickle cell treatment demonstration program | $100,000 |
| Childrens Hospital Los Angeles | Subcontract hrsa grant hemophilia regional comprehensive care program | $88,282 |
| The Board of Trustees of the Leland Stanford Junior University | Subcontract hrsa grant hemophilia regional comprehensive care program | $83,906 |
Explore more
Data for Center For Comprehensive Care and Diagnosis of Inherited Blood (EIN 27-0179192) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.